|
1
|
Basnayake SK and Easterbrook PJ: Wide
variation in estimates of global prevalence and burden of chronic
hepatitis B and C infection cited in published literature. J Viral
Hepat. 23:545–559. 2016. View Article : Google Scholar
|
|
2
|
GBD 2013 Mortality and Causes of Death
Collaborators, . Global, regional, and national age-sex specific
all-cause and cause-specific mortality for 240 causes of death,
1990–2013: A systematic analysis for the global burden of disease
study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar
|
|
3
|
Lok AS and McMahon BJ: Chronic hepatitis
B. Hepatology. 45:507–539. 2007. View Article : Google Scholar
|
|
4
|
Liu WP, Wang XP, Zheng W, Ping LY, Zhang
C, Wang GQ, Song YQ and Zhu J: Hepatitis B virus reactivation after
withdrawal of prophylactic antiviral therapy in patients with
diffuse large B cell lymphoma. Leuk Lymphoma. 56:1355–1362. 2016.
View Article : Google Scholar
|
|
5
|
Jia Y, Zeng Z, Li Y, Li Z, Jin L, Zhang Z,
Wang L and Wang FS: Impaired function of CD4+ T follicular helper
(Tfh) cells associated with hepatocellular carcinoma progression.
PLoS One. 10:e01174582015. View Article : Google Scholar :
|
|
6
|
Zgair AK, Ghafil JA and AI-Sayidi RH:
Direct role of antibody-secreting B cells in the severity of
chronic hepatitis B. J Med Virol. 87:407–416. 2015. View Article : Google Scholar
|
|
7
|
Zhao PW, Shi X, Li C, Ayana DA, Niu JQ,
Feng JY, Wang J and Jiang YF: IL-33 enhances humoral immunity
against chronic HBV infection through activating CD4(+)CXCR5(+) TFH
cells. J Interferon Cytokine Res. 35:454–463. 2015. View Article : Google Scholar :
|
|
8
|
Hu TT, Song XF, Lei Y, Hu HD, Ren H and Hu
P: Expansion of circulating TFH cells and their associated
molecules: Involvement in the immune landscape in patients with
chronic HBV infection. Virol J. 11:542014. View Article : Google Scholar :
|
|
9
|
Morita R, Schmitt N, Bentebibel SE,
Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S,
Sabzghabaei N, et al: Human blood CXCR5(+)CD4(+) T cells are
counterparts of T follicular cells and contain specific subsets
that differentially support antibody secretion. Immunity.
34:108–121. 2011. View Article : Google Scholar :
|
|
10
|
Crotty S: Follicular helper CD4 T cells
(TFH). Annu Rev Immunol. 29:621–663. 2011. View Article : Google Scholar
|
|
11
|
Tangye SG, Ma CS, Brink R and Deenick EK:
The good, the bad and the ugly-TFH cells in human health and
disease. Nat Rev Immunol. 13:412–426. 2013. View Article : Google Scholar
|
|
12
|
King C, Tangye SG and Mackay CR: T
follicular helper (TFH) cells in normal and dysregulated immune
responses. Annu Rev Immunol. 26:741–766. 2008. View Article : Google Scholar
|
|
13
|
Chakravarti N and Prieto VG: Predictive
factors of activity of anti-programmed death-1/programmed death
ligand-1 drugs: Immunohistochemistry analysis. Transl Lung Cancer
Res. 4:743–751. 2015.
|
|
14
|
Lee V and Le DT: Efficacy of PD-1 blockade
in tumors with MMR deficiency. Immunotherapy. 8:1–3. 2016.
View Article : Google Scholar
|
|
15
|
Radhakrishnan P, Chachadi V, Lin MF, Singh
R, Kannagi R and Cheng PW: TNFα enhances the motility and
invasiveness of prostatic cancer cells by stimulating the
expression of selective glycosyl- and sulfotransferase genes
involved in the synthesis of selectin ligands. Biochem Biophys Res
Commun. 409:436–441. 2011. View Article : Google Scholar :
|
|
16
|
Egberts JH, Cloosters V, Noack A,
Schniewind B, Thon L, Klose S, Kettler B, von Forstner C, Kneitz C,
Tepel J, et al: Anti-tumor necrosis factor therapy inhibits
pancreatic tumor growth and metastasis. Cancer Res. 68:1443–1450.
2008. View Article : Google Scholar
|
|
17
|
Stathopoulos GT, Kollintza A, Moschos C,
Psallidas I, Sherrill TP, Pitsinos EN, Vassiliou S, Karatza M,
Papiris SA, Graf D, et al: Tumor necrosis factor-alpha promotes
malignant pleural effusion. Cancer Res. 67:9825–9834. 2007.
View Article : Google Scholar
|
|
18
|
Mendez M and LaPointe MC: PGE2-induced
hypertrophy of cardiac myocytes involves EP4 receptor-dependent
activation of p42/44 MAPK and EGFR transactivation. Am J Phys Heart
Circ Physiol. 288:H2111–H2117. 2005. View Article : Google Scholar
|
|
19
|
Krysan K, Reckamp KL, Dalwadi H, Sharma S,
Rozengurt E, Dohadwala M and Dubinett SM: Prostaglandin E2
activates mitogen-activated protein kinase/Erk pathway signaling
and cell proliferation in non-small cell lung cancer cells in an
epidermal growth factor receptor-independent manner. Cancer Res.
65:6275–6281. 2005. View Article : Google Scholar
|
|
20
|
Xu F, Xu Z, Zhang R, Wu Z, Lim JH, Koga T,
Li JD and Shen H: Nontypeable Haemophilus influenzae induces COX-2
and PGE2 expression in lung epithelial cells via activation of p38
MAPK and NF-kappa B. Respir Res. 9:162008. View Article : Google Scholar :
|
|
21
|
Zhang Z, Chen D, Yao J, Zhang H, Jin L,
Shi M, Zhang H and Wang FS: Increased infiltration of intrahepatic
DC subsets closely correlate with viral control and liver injury in
immune active pediatric patients with chronic hepatitis B. Clin
Immunol. 122:173–180. 2007. View Article : Google Scholar
|
|
22
|
Lok AS and McMahon BJ: Chronic hepatitis
B. Hepatology. 45:507–539. 2007. View Article : Google Scholar
|
|
23
|
Pan CQ and Zhang JX: Natural history and
clinical consequences of hepatitis B Virus infection. Int J Med
Sci. 2:36–40. 2005. View Article : Google Scholar :
|
|
24
|
Lan P, Zhang C, Han Q, Zhang J and Tian Z:
Therapeutic recovery of hepatitis B virus (HBV)-induced
hepatocyte-intrinsic immune defect reverses systemic adaptive
immune tolerance. Hepatology. 58:73–85. 2013. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Chen JH, Perry CJ, Tsui YC, Staron MM,
Parish IA, Dominguez CX, Rosenberg DW and Kaech SM: Prostaglandin
E2 and programmed cell death 1 signaling coordinately impair CTL
function and survival during chronic viral infection. Nat Med.
21:327–334. 2015. View
Article : Google Scholar :
|
|
27
|
Chen S, Liu C, Wang X, Li X, Chen Y and
Tang N: 15-Deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) promotes
apoptosis of HBx-positive liver cells. Chem Biol Interact.
214:26–32. 2014. View Article : Google Scholar
|
|
28
|
Zgair AK, Ghafil JA and Al-Sayidi RH:
Direct role of antibody-secreting B cells in the severity of
chronic hepatitis B. J Med Virol. 87:407–416. 2015. View Article : Google Scholar
|
|
29
|
Wang F, Xu RH, Luo HY, Zhang DS, Jiang WQ,
Huang HQ, Sun XF, Xia ZJ and Guan ZZ: Clinical and prognostic
analysis of hepatitis B virus infection in diffuse large B-cell
lymphoma. BMC Cancer. 8:1152008. View Article : Google Scholar :
|
|
30
|
Bussmann BM, Reiche S, Bieniek B, Krznaric
I, Ackermann F and Jassoy C: Loss of HIV-specific memory B-cells as
a potential mechanism for the dysfunction of the humoral immune
response against HIV. Virology. 397:7–13. 2010. View Article : Google Scholar
|
|
31
|
Töpfer E, Boraschi D and Italiani P:
Innate Immune Memory: The latest frontier of adjuvanticity. J
Immunol Res. 2015:4784082015. View Article : Google Scholar :
|
|
32
|
Fazilleau N, Mark L, McHeyzer-Williams LJ
and McHeyzer-Williams MG: Follicular helper T cells: Lineage and
location. Immunity. 30:324–335. 2009. View Article : Google Scholar :
|
|
33
|
McHeyzer-Williams LJ, Pelletier N, Mark L,
Fazilleau N and McHeyzer-Williams MG: Follicular helper T cells as
cognate regulators of B cell immunity. Curr Opin Immunol.
21:266–273. 2009. View Article : Google Scholar :
|
|
34
|
Feng J, Lu L, Hua C, Qin L, Zhao P, Wang
J, Wang Y, Li W, Shi X and Jiang Y: High frequency of CD4+ CXCR5+
TFH cells in patients with immune-active chronic hepatitis B. PLoS
One. 6:e216982011. View Article : Google Scholar :
|
|
35
|
Zheng BY, Fang XF, Zou LY, Huang YH, Chen
ZX, Li D, Zhou LY, Chen H and Wang XZ: The co-localization of HBx
and COXIII upregulates COX-2 promoting HepG2 cell growth. Int J
Oncol. 45:1143–1150. 2014.
|
